Racial differences in the prevalence of Factor V Leiden mutation among patients on chronic warfarin therapy
- 31 October 2006
- journal article
- research article
- Published by Elsevier BV in Blood Cells, Molecules, and Diseases
- Vol. 37 (2), 100-106
- https://doi.org/10.1016/j.bcmd.2006.06.003
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Factor V Leiden, prothrombin 20210A, methylenetetrahydrofolate reductase 677T, and population geneticsMolecular Genetics and Metabolism, 2005
- Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studiesAmerican Heart Journal, 2003
- Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analysesBlood, 2002
- Genetic Susceptibility to Venous ThrombosisThe New England Journal of Medicine, 2001
- Epidemiology of Factor V Leiden: Clinical ImplicationsSeminars in Thrombosis and Hemostasis, 1998
- Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screeningPublished by American Medical Association (AMA) ,1997
- Ischemic Stroke in the ElderlyStroke, 1996
- Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutationThe Lancet, 1994
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Caucasian Genes in American NegroesScience, 1969